Brian Culley

Company: Lineage Cell Therapeutics

Job title: Chief Executive Officer

Seminars:

Lineage Cell Therapeutics (LCTX): Applying Cell Therapy to Areas of Unmet Medical Need 9:00 am

Examine OpRegen: An RPE transplant therapy in a Phase 1/2a trial for the treatment of dry-AMD with geographic atrophy Explore OPC1: An oligodendrocyte progenitor therapy for acute spinal cord injuries with Orphan and RMAT designations; phase 1 completed Discuss VAC2: An allogeneic cancer immunotherapy of antigenpresenting dendritic cells currently in a Phase 1 for oncologyRead more

day: Day Two